Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas.
COVID-19 samples
Pre-COVID-19 samples
SARS-CoV-2 S protein
cross-reactivity
malaria endemic-area
seroreactivity
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2022
2022
Historique:
received:
16
01
2022
accepted:
28
03
2022
entrez:
19
5
2022
pubmed:
20
5
2022
medline:
21
5
2022
Statut:
epublish
Résumé
Despite the global interest and the unprecedented number of scientific studies triggered by the COVID-19 pandemic, few data are available from developing and low-income countries. In these regions, communities live under the threat of various transmissible diseases aside from COVID-19, including malaria. This study aims to determine the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroreactivity of antibodies from COVID-19 and pre-COVID-19 samples of individuals in Mali (West Africa). Blood samples from COVID-19 patients (n = 266) at Bamako Dermatology Hospital (HDB) and pre-COVID-19 donors (n = 283) from a previous malaria survey conducted in Dangassa village were tested by ELISA to assess IgG antibodies specific to the full-length spike (S) protein, the receptor-binding domain (RBD), and the receptor-binding motif (RBM
Identifiants
pubmed: 35585976
doi: 10.3389/fimmu.2022.856033
pmc: PMC9109707
doi:
Substances chimiques
Antibodies, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
856033Informations de copyright
Copyright © 2022 Traoré, Guindo, Konaté, Traoré, Diakité, Kanté, Dembélé, Cissé, Incandela, Kodio, Coulibaly, Faye, Kajava, Pratesi, Migliorini, Papini, Pacini, Rovero, Errante, Diakité, Arevalo-Herrera, Herrera, Corradin and Balam.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Immun Inflamm Dis. 2021 Jun;9(2):331-339
pubmed: 33566457
BMC Infect Dis. 2021 Jul 5;21(1):647
pubmed: 34225644
J Immunol Methods. 1985 Dec 27;85(2):409-19
pubmed: 4078319
Travel Med Infect Dis. 2020 May - Jun;35:101758
pubmed: 32479815
J Infect Dis. 2013 Nov 15;208(10):1634-42
pubmed: 23922367
Front Immunol. 2020 Aug 11;11:1991
pubmed: 32903476
Emerg Infect Dis. 2021 Jan;27(1):
pubmed: 33261717
FEBS J. 2005 Oct;272(20):5101-9
pubmed: 16218944
Mol Cell Proteomics. 2002 Nov;1(11):845-67
pubmed: 12488461
New Microbes New Infect. 2020 Nov;38:100817
pubmed: 33230417
Science. 2020 Dec 11;370(6522):1339-1343
pubmed: 33159009
Vaccine. 2011 Sep 16;29(40):7090-9
pubmed: 21803099
J Immunol Methods. 2006 Feb 20;309(1-2):200-4
pubmed: 16406059
J Clin Med. 2020 Apr 16;9(4):
pubmed: 32316118
Engineering (Beijing). 2021 Oct;7(10):1441-1451
pubmed: 32904601
Anal Chem. 2006 Jan 1;78(1):135-40
pubmed: 16383320
Discoveries (Craiova). 2020 Dec 11;8(4):e120
pubmed: 33365386
Trop Med Health. 2020 Jun 3;48:41
pubmed: 32514230
Diabetes Metab Res Rev. 2021 Feb;37(2):e3377
pubmed: 32588943
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
mSphere. 2020 Sep 16;5(5):
pubmed: 32938700
Diabetes Obes Metab. 2020 Oct;22(10):1915-1924
pubmed: 32573903
Front Physiol. 2021 Jan 12;11:571416
pubmed: 33510644
Viruses. 2020 Nov 02;12(11):
pubmed: 33147840
J Med Virol. 2021 Jul;93(7):4242-4246
pubmed: 33710634
Lancet Microbe. 2020 Aug;1(4):e151
pubmed: 33521716
Metabolism. 2020 Jul;108:154262
pubmed: 32422233
J Adv Res. 2020 Mar 16;24:91-98
pubmed: 32257431
Science. 2020 Aug 7;369(6504):650-655
pubmed: 32571838
Health Res Policy Syst. 2020 Sep 17;18(1):105
pubmed: 32943078
N Engl J Med. 2012 Nov 8;367(19):1814-20
pubmed: 23075143
J Parasitol Res. 2020 Dec 02;2020:8829848
pubmed: 33354370
Nat Struct Mol Biol. 2020 Oct;27(10):934-941
pubmed: 32737467
Nat Med. 2020 Jun;26(6):845-848
pubmed: 32350462
Euro Surveill. 2020 Apr;25(16):
pubmed: 32347204
Nature. 2021 Feb;590(7844):140-145
pubmed: 33137809
Clin Infect Dis. 2020 Jul 28;71(15):778-785
pubmed: 32198501
Cell Mol Immunol. 2020 Jul;17(7):773-775
pubmed: 32467617
Trends Immunol. 2020 May;41(5):355-359
pubmed: 32249063
J Med Virol. 2020 Oct;92(10):1724-1727
pubmed: 32227490
Clin Infect Dis. 2019 Jan 18;68(3):466-474
pubmed: 29945169
Cell Rep. 2020 Jun 2;31(9):107725
pubmed: 32426212
Am J Trop Med Hyg. 2021 Mar 01;104(4):1342-1347
pubmed: 33646974
J Appl Lab Med. 2020 Sep 1;5(5):908-920
pubmed: 32428207
Sci Rep. 2022 Dec 22;12(1):22175
pubmed: 36550362
CMAJ. 2020 Sep 8;192(36):E1041-E1045
pubmed: 32900766
Endocr Metab Immune Disord Drug Targets. 2007 Dec;7(4):259-65
pubmed: 18220946
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Eur Respir J. 2020 Aug 27;56(2):
pubmed: 32430429
Respirology. 2020 Jul;25(7):680-682
pubmed: 32436320
Emerg Microbes Infect. 2020 Dec;9(1):940-948
pubmed: 32357808
Int J Mol Sci. 2020 Jun 22;21(12):
pubmed: 32580529
Cell Mol Immunol. 2020 Jun;17(6):613-620
pubmed: 32203189
Sci Rep. 2020 Oct 6;10(1):16561
pubmed: 33024213
Science. 2020 Dec 4;370(6521):1227-1230
pubmed: 33115920
Malar J. 2020 Dec 23;19(1):457
pubmed: 33357220
J Transl Med. 2020 Jun 3;18(1):222
pubmed: 32493510
Sci Transl Med. 2020 Sep 2;12(559):
pubmed: 32817357
PLoS One. 2020 Nov 23;15(11):e0241164
pubmed: 33227020
Front Immunol. 2020 Sep 17;11:570018
pubmed: 33042151
Biosaf Health. 2021 Aug;3(4):230-234
pubmed: 33969285
Clin Exp Immunol. 1983 Jan;51(1):165-72
pubmed: 6299636
PLoS Pathog. 2020 Jun 22;16(6):e1008570
pubmed: 32569293
Antiviral Res. 2020 Jul;179:104820
pubmed: 32405117
Nature. 2021 Feb;590(7844):146-150
pubmed: 33142304
Biochem J. 2004 Oct 1;383(Pt 1):45-51
pubmed: 15283675
Clin Infect Dis. 2020 Nov 5;71(8):1930-1934
pubmed: 32306047
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
J Clin Microbiol. 2021 Jun 18;59(7):e0051421
pubmed: 33853839
Cell. 2021 Mar 4;184(5):1201-1213.e14
pubmed: 33571429
Nat Commun. 2021 Jan 22;12(1):542
pubmed: 33483491
Nature. 2020 Dec;588(7837):315-320
pubmed: 32846427
Microbes Infect. 2020 May - Jun;22(4-5):206-211
pubmed: 32425648
Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
pubmed: 9254694
Yale J Biol Med. 1983 Sep-Dec;56(5-6):639-42
pubmed: 6433575
Emerg Infect Dis. 2020 Jul;26(7):1478-1488
pubmed: 32267220
Eur Respir J. 2020 May 14;55(5):
pubmed: 32217650
Int J Infect Dis. 2021 Mar;104:159-163
pubmed: 33383223
Clin Kidney J. 2021 Mar 09;14(7):1835-1844
pubmed: 34211708
Crit Care. 2017 Dec 13;21(1):305
pubmed: 29237475
Nat Commun. 2020 Sep 17;11(1):4704
pubmed: 32943637
J Med Virol. 2021 Apr;93(4):2196-2203
pubmed: 33107601
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Methods Mol Biol. 2015;1282:1-23
pubmed: 25720466
Nat Med. 2004 Dec;10(12 Suppl):S88-97
pubmed: 15577937
mBio. 2020 Sep 25;11(5):
pubmed: 32978311
Front Immunol. 2020 Aug 28;11:2147
pubmed: 32983176
Curr Opin Immunol. 2007 Jun;19(3):268-74
pubmed: 17433875
IDCases. 2020 Jun 20;21:e00879
pubmed: 32665888
Ageing Res Rev. 2021 Jan;65:101205
pubmed: 33137510
Nat Med. 2020 Apr;26(4):506-510
pubmed: 32284616
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
J Med Virol. 2020 Oct;92(10):2050-2054
pubmed: 32383183
Signal Transduct Target Ther. 2021 Feb 26;6(1):95
pubmed: 33637679
Eur J Immunol. 1982 Aug;12(8):634-41
pubmed: 6982814
Amino Acids. 2004 Dec;27(3-4):249-59
pubmed: 15592754